64.71MINR
Type
Common Stock
Exchange
BSE
Currency Code
INR
Currency Name
Indian Rupee
Country Name
India
Country ISO
IN
ISIN
INE518E01015
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
95.80
PEG Ratio
-
Book Value
53.27
Dividend Share
-
Dividend Yield
-
Earnings Share
1.19
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
3,744,001,024
Gross Profit TTM
1,974,483,968
EBITDA
248,372,992
Profit Margin
1.56%
Return On Assets TTM
1.27%
Return On Equity TTM
2.13%
Revenue Per Share TTM
76.441
Qtly Revenue Growth YOY
-3.20%
Diluted Eps TTM
1.19
Qtly Earnings Growth YOY
-24.90%
Trailing PE
95.80
Forward PE
0
Price Sales TTM
1.6305
Price Book MRQ
1.9646
Enterprise Value Revenue
1
Enterprise Value EBITDA
16
1112.10
2.56%1112.20
2.44%4514.10
1.28%4514.15
1.27%1433.10
1.23%2357.80
0.76%2356.55
0.73%1867.80
0.23%6743.15
-0.62%6747.00
-0.60%